At a glance
ClinicalIndex Comparison RecordN/ACompleted· 26 enrolled
Drug / intervention
Hemochron +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Activated Coagulation Time Between Hemochron Jr and ACT Plus During Cardiac Surgery for Patient Using Acute Normovolemic Hemodilution
In Brief
A clinical study evaluating Hemochron and ACT Plus for Cardiac Disease. Completed, enrolled 26 participants across 1 site.
Detailed Summary
This study aimed to compare 2 activated clotting time analysers (Hemochron Jr vs. ACT Plus).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Disease
CountriesSouth Korea
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2012
Primary CompletionDec 2013
Study CompletionJan 2014
First PostedJun 2015
TodayJul 2026
First PostedJun 29, 2015
Enrollment StartDec 1, 2012
Primary CompletionDec 1, 2013
Study CompletionJan 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 11.0 years ago
Interventions
Hemochrondevice
Activated coagulation time was checked serially by Hemochron Jr.
ACT Plusdevice
Activated coagulation time was checked serially by ACT Plus.